We are proud to share a newly published article regarding TAE for unresectable HCC.

Survival analysis of 230 patients with unresectable hepatocellular carcinoma treated with bland transarterial embolization

It’s the summary of ten years worth of treatments, confrontation, and studying.

Glubran 2 has done its work!